News & Events
2020
Kyowa Hakko Bio Establishes New Facility in Thailand to Supply Human Milk Oligosaccharides Worldwide
November 6, 2020PRWeb.comKYOWA HAKKO BIO CO. LTD. (Kyowa Hakko Bio), a subsidiary of Kirin Holdings Company, Limited (Kirin Holdings), has announced that it will establish a new facility to manufacture human milk oligosaccharides (HMOs) in Thailand. Kyowa Hakko Bio decided on the move with expectations of a future increase in global demand for HMOs. This move further expands its global footprint to consolidate its position as a global specialty fermentation manufacturer. Read more »
Kyowa Hakko Announces “IMMUSE™ LC-Plasma: A Unique Approach to Immune Health” Live Webinar
October 6, 2020Leading international health ingredient manufacturer Kyowa Hakko is excited to announce an interactive webinar will be held on Wednesday, October 7th at 2:00pm EDT with Natural Products Insider to discuss, and educate, on the newest approach that supports the immune system. Read more »
Triple Threat – Glaxon’s New and Improved Plasm Surge Blend Features Three of Kyowa Hakko’s Branded Ingredients
October 5, 2020Sports nutrition dietary supplement brand Glaxon launches Plasm Surge, a non-stimulant pre-workout product with a new and improved formula and flavor system, featuring leading international health-ingredient manufacturer Kyowa Hakko’s Setria® Performance Blend, Velox® Patented Performance Blend and Kyowa Quality L-Citrulline. Read more »
The Latest Breakthrough Approach in Immunity – IMMUSE™ Enters the U.S. Market
September 28, 2020New York, NY, USAInternational health ingredient manufacturer Kyowa Hakko Bio Co., Ltd. (Kyowa Hakko) and parent company Kirin Holdings Co., Ltd., (Kirin Holdings) announce the launch of its novel dietary supplement ingredient IMMUSE™, delivering a new approach for broad range immune support. Read more »
'Know Your Potential' with Knosis – Cognizin® Citicoline Featured in New Nootropic + Energy Blend
September 17, 2020New Gamer-Focused Supplement launches with Kyowa Hakko’s brain health ingredient in science-backed, transparent formula. Dietary supplement brand Knosis enters the market with the launch of its powdered Energy + Nootropic mix, a science-backed formula designed by Knosis’ founder Erik Bywater to optimally support eSports performance and energy. Read more »
Senior Pharmaceutical Drug Development Executive, Philip Chaikin, PharmD, MD, FCP, Joins NDA Partners as Expert Consultant
June 17, 2020NDA Partners Chairman Carl Peck, MD, announced today that Dr. Philip Chaikin, a senior pharmaceutical industry executive with extensive drug development experience in development strategy, regulatory strategy, clinical pharmacology, and clinical study design, has joined the firm as an Expert Consultant. Read more »
Kyowa Hakko’s American-Made L-Glutamine Ingredient Featured in New Healthy Origins Product
June 15, 2020With a mission to provide consumers with “healthy value from reliable origins,” Healthy Origins introduces its new L-Glutamine dietary supplement product, formulated exclusively with Kyowa Hakko’s American-made, researched-backed L-Glutamine ingredient. Read more »
Juggernaut Launches “The Next Generation of Clean Energy Drinks” with New Products Featuring Kyowa Hakko’s branded Cognizin® Citicoline
June 11, 2020Founded by Sean Kinahan and Denver Hardin, Juggernaut Energy enters the market with its cutting-edge, zero-sugar energy powders formulated with clinically-studied brain health ingredient Cognizin® Citicoline. The dynamic duo was determined to create a clean, healthy energy drink without the hefty crash later on. Read more »
Kyowa Hakko USA Takes Action to Support Health Care Workers and Customers
May 22, 2020Global leaders in the research, manufacturing and purification of high-quality health ingredients, Kyowa Hakko USA took the initiative to provide support for NYC health care workers on the frontlines while also partnering with ingredient customer on a unique program. Read more »
Kyowa Hakko USA Introduces New VELOX® Patented Performance Blend
April 29, 2020Kyowa Hakko USA announces the launch of VELOX® Patented Performance Blend, a clinically studied combination of Kyowa’s L-Citrulline and Kyowa’s L-Arginine that has been shown to increase Nitric Oxide production and to boost Nitric Oxide levels more rapidly than L-Arginine alone*. Read more »
Mediaplanet and the Cameron Boyce Foundation Team Up for Neurological Disorders Awareness
March 31, 2020In recognition of Brain Awareness Week and ahead of Parkinson’s Awareness Month, Mediaplanet is proud to announce the launch of its “Neurological Disorders” campaign. Up to one billion people, nearly one-sixth of the world’s population, suffer from neurological disorders, with some 6.8 million dying of the disorders each year. There is no cure for any of these disorders, and patients, healthcare professionals, and family caregivers alike are in desperate need of improved therapies and technologies that will help manage their symptoms and improve their quality of life. Read more »
Copyright © 1998 – 2023 by KYOWA HAKKO U.S.A., INC. All Rights Reserved. | AWS
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.